Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
The glucagon receptor component adds energy expenditure and lipolysis effects not seen in dual agonists, which may explain the larger effect sizes in Phase II data
Some agonists also help treat obesity
Regulatory Number: KKLIU 1855, valid until 31 December 2027
As of mid-2026, retatrutide has not been approved by the MHRA in the UK or the FDA in the United States
What is peptide therapy
Reactive intermediates react mainly with polyunsaturated fatty acids (PUFAs), which leads to lipoperoxyl radicals generation, that further interact with lipids, forming lipid radicals and lipid hydroperoxides
US$ 25.56
US$ 20.93
US$ 22.90
US$ 24.97
US$ 22.87
US$ 22.95
